Humana Inc. (HUM)
Is Humana (HUM) Stock Outpacing Its Medical Peers This Year?
Here is how Humana (HUM) and Envoy Medical, Inc. (COCH) have performed compared to their sector so far this year.
Can Humana (HUM) Run Higher on Rising Earnings Estimates?
Humana (HUM) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?
Humana targets a 3% Medicare Advantage margin by 2028 while pursuing 25% 2026 membership growth and rebuilding profitability despite industry headwinds.
How CenterWell Is Driving Humana's Growth Beyond Insurance
CenterWell's rapid growth is helping HUM expand beyond insurance with integrated care, acquisitions, AI and a 2026 revenue target of at least $25B.
Can Humana's Margin Recovery Drive Long-Term Earnings Growth?
HUM is shifting from membership growth to profitability, with lower medical costs, rising CenterWell revenues, and a margin recovery plan through 2028.
Humana Closes the Kindred Chapter With $900 Million Gentiva Exit
HUM is cashing out its Gentiva stake for $900 million, completing a multiyear effort to sharpen focus on its core health insurance business.
Humana To Divest End-Of-Life Care Business For $900 Million
Humana, one of the nation's largest providers of privatized Medicare Advantage health insurance for older adults, announced plans to divest its minority stake in a provider of end-of-life services for $900 million.
Humana divests minority stake in hospice provider Gentiva
Humana said on Wednesday it has agreed to sell all or substantially all of its minority stake in Gentiva, a provider of hospice and palliative care services, in a deal valuing the stake at about $900 million.
As Tech Stocks Slide, The Healthcare Sector Shines. Why Some Experts Say They Like This Defensive Play
Tech stocks are pulling back, and healthcare is surging.
Humana Jumps 6%, UnitedHealth Climbs 5%, Cigna Rises 4% as Analysts Cheer Softer Medical Cost Trends
Health insurers are running higher in Thursday afternoon trading after a wave of bullish Wall Street analyst notes on the managed-care sector, centered on UnitedHealth, citing softer medical cost and utilization trends plus potential AI efficiency upside.
Humana (HUM) Up 30.6% Since Last Earnings Report: Can It Continue?
Humana (HUM) reported earnings 30 days ago. What's next for the stock?
Humana Just Got a Massive Upgrade From Deutsche Bank: Price Target Nearly Doubles to $441
Deutsche Bank just delivered one of the most aggressive analyst upgrades of 2026 on Humana (NYSE:HUM | HUM Price Prediction), lifting the managed care giant to Buy from Hold while nearly doubling its price target to $441 from $235.
